Eli Lilly (LLY) Net Income towards Common Stockholders (2009 - 2026)
Eli Lilly (LLY) reported Net Income towards Common Stockholders of $7.1 billion for Q2 2026, up 25.3% from $5.66 billion a year earlier but down 4.1% from the prior quarter.
Powered by 
Analysis
Eli Lilly (LLY) Net Income towards Common Stockholders (2009 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Eli Lilly's Net Income towards Common Stockholders came in at $26.71 billion, up 93.6% year-over-year; for FY2025, it was $20.64 billion, up 94.9% from FY2024.
- Net Income towards Common Stockholders has a five-year compound annual growth rate of 27.2% (FY2020 to FY2025).
- By year, Net Income towards Common Stockholders came in at $10.59 billion in FY2024 (+102.1%), $5.24 billion in FY2023 (-16.1%), $6.24 billion in FY2022 (+11.9%) and $5.58 billion in FY2021 (-9.9%).
- Five-year quarterly Net Income towards Common Stockholders spans a low of -$57.4 million in Q3 2023 and a high of $7.4 billion in Q1 2026.
- Year over year, Net Income towards Common Stockholders has now increased in each of the last seven quarters, with growth averaging 133.5% over the last seven quarters.
- The high point for year-over-year Net Income towards Common Stockholders in five years was Q3 2025 (growth of 475.3%); the low point was Q2 2022 (a decline of 31.5%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $7.4 billion (Q1 2026), $6.64 billion (Q4 2025) and $5.58 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 7.10 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 5.53 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.61 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -1.34 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 3.26 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 2.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 2.38 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -10.50 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | -248.00 Mn |
| 10 | Vertex Pharmaceuticals | 127.87 Bn | 99.88 Bn | 2.84 Bn | 1.10 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.10 Bn |
| Mar 31, 2026 | 7.40 Bn |
| Dec 31, 2025 | 6.64 Bn |
| Sep 30, 2025 | 5.58 Bn |
| Jun 30, 2025 | 5.66 Bn |
| Mar 31, 2025 | 2.76 Bn |
| Dec 31, 2024 | 4.41 Bn |
| Sep 30, 2024 | 970.30 Mn |
| Jun 30, 2024 | 2.97 Bn |
| Mar 31, 2024 | 2.24 Bn |
| Dec 31, 2023 | 2.19 Bn |
| Sep 30, 2023 | -57.40 Mn |
| Jun 30, 2023 | 1.76 Bn |
| Mar 31, 2023 | 1.34 Bn |
| Dec 31, 2022 | 1.94 Bn |
| Sep 30, 2022 | 1.45 Bn |
| Jun 30, 2022 | 952.50 Mn |
| Mar 31, 2022 | 1.90 Bn |
| Dec 31, 2021 | 1.73 Bn |
| Sep 30, 2021 | 1.11 Bn |
API Access
Eli Lilly Net Income towards Common Stockholders API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=LLY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income-towards-common-stockholders", "ticker": "LLY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=LLY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();